Sign in
4

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0001567619-21-008410

Director bought 385 shares at $12.77 ($4,916)

From the SEC's structured data for this filing

Trades in this filing

Peyer James · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-04-20 Purchase : show line 1 in the form +385 $12.77 $4,916 4,811,894 I
Open-market purchases · 385 sh · avg $12.77 · $4,916
Loading xslF345X03/doc1.xml…